Lycia Therapeutics, Inc.
LYCANasdaqSEC Central Index Key: 0001806540
SEC Entity Profile
SIC Industry2836 — Biological Products, (No Diagnostic Substances)
Entity Typeother
State of IncorporationDE
Fiscal Year End1231
Listing (Nasdaq Trader)
Symbol Directory: LYCA → Listing Exchange Nasdaq (Q)
Market Category Global Select (Q)
Security Type Common Stock (C)
ETF No
Round Lot Size 100 shares
Financial Status Normal (N)
Test Issue No
Listed Since on or before 2026-10-24
SEC Ticker Equivalent LYCA
Regulatory Flags (Nasdaq Trader)
Symbol: LYCARule 201 Short Sale Circuit Breakers Triggered
Alternative uptick rule (Rule 201) triggered by a ≥10% price decline from previous day's close (most recent first, up to 50 triggers).
| Trade Date | Trigger Time (ET) |
|---|---|
| 2026-10-28 | 2026-10-27T10:14:51 |
| 2026-10-27 | 2026-10-26T09:30:00 |
| 2026-10-26 | 2026-10-26T09:30:00 |
Query Point-in-Time Interval
Enter any past date to resolve the active security mapping without lookahead bias.
Point-in-Time Ticker Interval Timeline
1 total historical interval| Status | Ticker | Company Name | Exchange | Valid From (UTC) | Valid To (UTC) |
|---|---|---|---|---|---|
| CURRENT | LYCA | Lycia Therapeutics, Inc. | Nasdaq | 2026-10-24 06:01:07 UTC | Current |
Nasdaq Trader Listing Event History
2 events recorded| Date | Event Kind | Description |
|---|---|---|
| 2026-10-23 | ADD | Trading system action: Add (Market: Nasdaq) - Lycia Therapeutics, Inc. |
| 2026-10-24 | FIRST_SEEN | Initial listing on Nasdaq (Global Select) |
Nasdaq Trader daily captures since 2026-09-20